National study of adrenal tumors
Part of Cancer, Hormones & metabolism clinical trials.
This study is collecting information from people with certain adrenal gland tumors (pheochromocytoma, paraganglioma, or adrenocortical tumor). It aims to learn more about these conditions, which may help improve future care. Both living and deceased patients can be included.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of pheochromocytoma, paraganglioma, or adrenocortical tumor (rare adrenal gland tumors) based on biopsy, blood/urine tests, or imaging
- Or you have a confirmed genetic change linked to pheochromocytoma or paraganglioma
- You are 18 years or older
- You are able to give your own permission to join the study
- You can follow the study requirements
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called belzutifan to see how it affects hormone levels in people with rare adrenal tumors (pheochromocytoma or paraganglioma). It may help control symptoms caused by excess hormones.
This study looks at people who have been newly diagnosed with pheochromocytoma/paraganglioma (PPGL), those with a past history of PPGL, or those with genetic risk for it. It may help doctors better evaluate and understand PPGL using specific tests.
This study looks at how the immune system responds to rare adrenal or nerve-related tumors (pheochromocytoma and paraganglioma). Researchers want to understand the tumor's environment, which may help improve future treatments.
This study helps doctors better understand and diagnose pheochromocytoma and paraganglioma—rare tumors that release stress hormones and cause high blood pressure and other symptoms. Researchers will study your medical history, blood and urine tests, imaging scans, and genetic information to improve how these conditions are found and understood.
This study looks at genetic (DNA) changes in people with pheochromocytoma or paraganglioma and related conditions. It may help clarify why these conditions happen and how they run in families.
This study follows adults with a new adrenal diagnosis to learn how adrenal diseases behave over time. It may help doctors better understand these conditions and improve future care.
Hear when a new Pheochromocytoma and Paraganglioma (PPGL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.